Serum vascular endothelial growth factor (VEGF) levels in ischemic stroke patients: a systematic review and meta-analysis of case–control studies
- 5 September 2020
- journal article
- review article
- Published by Springer Nature in Neurological Sciences
- Vol. 42 (5) , 1811-1820
Abstract
Serum VEGF level is regarded to be a biomarker for the diagnosis of stroke. Even though there have been published plethora of original articles describing higher blood VEGF concentrations since the 1970s, however, there is no any meta-analysis report for serum VEGF levels in the field of evidence-based medicine yet. A systematic review was performed by searching the online biomedical databases including retrieving 14 case–control studies including within-article subgroups after fulfilling the inclusion and exclusion criteria without the beginning date restriction, until 2020 for ischemic stroke patients. The Q quantity and I2% statistic index showed a high heterogeneity (84.895 and 84.687, respectively) and the random-effects model of meta-analysis was applied for further analyses. The meta-analysis on a total number of 769 stroke subjects and 621 controls found that the weighted pooled SMD for overall serum VEGF levels on different days of testing was 1.92 (95% CI, − 4.059–0.219, p value = 0.079) and the pooled SMD for overall serum VEGF levels on day 1 of testing was − 1.083 (95% CI, − 4.229–2.063, p value = 0.500). The meta-regression results demonstrated that different days of testing do not significantly affect serum VEGF concentrations in ischemic patients and actually their serum levels are time-independent. Based on the recently published studies, this meta-analysis showed that serum VEGF levels were not significantly associated with an ischemic stroke diagnosis. Thus, researchers may concern another ideal serum or cerebrospinal fluid-derived biomarker for stroke diagnosis.Keywords
This publication has 20 references indexed in Scilit:
- Clinical significance of plasma VEGF value in ischemic stroke - research for biomarkers in ischemic stroke (REBIOS) studyBMC Neurology, 2013
- Vascular endothelial growth factors (VEGFs) and strokeCellular and Molecular Life Sciences, 2013
- Beneficial Effects of Propolis on Neurological Disorders2012
- Interpreting estimates of treatment effects: implications for managed care.2008
- VEGF Protects Brain against Focal Ischemia without Increasing Blood–Brain Permeability When Administered IntracerebroventricularlyJournal of Cerebral Blood Flow & Metabolism, 2005
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-β1 in Serum of Patients With Acute Ischemic StrokeStroke, 2000
- An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient dataPain, 2000
- Serum Growth Factors and Neuroprotective SurveillanceMolecular Neurobiology, 2000